Navigation Links
Advent of New, More Effective and Personalized Medicines

The FDA today issued a final guidance titled "Pharmacogenomic Data Submissions" to speed// development of new medical products through the science of pharmacogenomics.

Pharmacogenomics allows health care providers to identify sources of an individual's profile of drug response and predict the best possible treatment option for this individual. This technology has enabled the development of targeted therapies like Herceptin for metastatic breast cancer, Gleevec for chronic myeloid leukemia and Erbitux for metastatic colorectal cancer.

This new approach will allow medicines to be uniquely crafted to maximize their therapeutic benefits and minimize the potential risks for each patient. Doctors will eventually be able to analyze a patient's genetic profile and prescribe the best available drug therapy and dose from the start.

FDA also approved the first laboratory test, the Amplichip Cytochrome P450 Genotyping Test, which will enable physicians to use genetic information to select the right doses of certain medications for cardiac, psychiatric diseases and cancer.

The final guidance describes what data will be needed during the marketing application review process, the format for submissions, and the data that will be used during regulatory decision-making. The guidance also explains a new mechanism for industry to voluntarily submit research data to further the scientific exchange of information as we move into more advanced areas of pharmacogenomic research.

The voluntary data, will be reviewed by an internal, agency-wide group and will not be used for regulatory decision making, but will help FDA and industry gain valuable experience. FDA believes this approach will save time and resources and eliminate possible delays in the application review process.

FDA has already received several pharmacogenomic data submissions through both the regulatory and voluntary processes and will continue to work cl
'"/>




Page: 1 2

Related medicine news :

1. Adventure Enthusiasts, Risk Takers and Those Living on the Edge, Good News Coming Your Way
2. Adrenaline Associated With Adventurers Risk Taking
3. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
4. Inhaled Steroids Safe & Effective for Children with Asthma
5. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
6. Fluoride Found Effective in Osteoporosis
7. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
8. Implantable Contact Lens Found Safe and Effective
9. Effective And Economical Agent For Anthrax
10. Stem Cell Transplants May Be Effective For MS Patients
11. Effective therapy for Huntingtons disease
Post Your Comments:
(Date:10/13/2008)...eading Content Rights Management System, Supports... Content Spend, WEST CHESTER, Pa., Oct. 13 /PRNew...ding global pharmaceutical manufacturer has integr...primary platform for the,secure distribution, data...cs for their new product video content. Imperium i...
(Date:10/13/2008)...swire/ -- The National Coalition for,Quality Color...ncerns over,the National CT Colonography Study pub...Medicine. The evidence must be closely evaluated, ...y is not without significant,potential risks. The ...py,remains the "Gold Standard" for colorectal canc...
(Date:10/13/2008)...blem in daily life, survey shows, PORTLAND, Ore.,...three-quarters of people living with psoriasis say...e, according to a National Psoriasis,Foundation 20...viduals with psoriasis and psoriatic arthritis,als...ly lives, shapes their,feelings about themselves a...
(Date:10/13/2008)...swire/ -- During the Pri-Med New York,conference a...are providers,took a 20-question quiz prepared by ...n Somerset, NJ. The quiz tested basic knowledge of..., EMR software, and healthcare,administration., T... The average number,of correct answers was only 7....
Breaking Medicine News(10 mins):Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3Health News:National Psoriasis Foundation Releases 2008 Study Results 2Health News:MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource 2
...t body issued a warning today that thousands of pe...ethal doses of radiation.// The warning issued b... (RPII) came after a house in Kerry was discovered...ceptable level of the deadly radioactive and cance...
...rning was issued by Britain's prime minister to th...products that were not-so- healthy to children or ...l ads that target minors. In a broad address on i...rned that in case of the voluntary regulations fai...
... bench of Allahabad High Court today stayed operat...ing 65 per cent seats in unaided private medical//...er government quota. A division bench comprising J...jeev Sharma granted the interim stay on the GO on ...
...ho are at a high risk for developing type 2 diabet...o take up weight training, according to researcher...researcher Michael Goran, PhD, professor of preven...cine of USC and colleagues were able to prove that...
Other Medicine News:Health News:Irish Households Exposed To Lethal Radiation 2Health News:Weight Training Can Ward Off Type 2 Diabetes In teenagers 2
(Date:10/13/2008)...SVILLE, Md., Oct. 13 /- Neuronascent,...day that the Company has received,funding from mul...vel,neurogenic compounds targeting Alzheimer,s di...eceived grants and funding from Maryland,Departmen...nvestment,Program; Maryland Industrial Partnership...
(Date:10/13/2008)...NTON, Mass., Oct. 13 /- Facet Solutio... follow-up on 20 patients from its US,IDE Pilot St...Disability,Index (ODI) scores, and an 80% reductio...g pain. Geoff Pardo, President & CEO for Facet Sol...ly results, which thus far not,only demonstrate si...
(Date:10/10/2008)...Z CREEK, Mich., Oct. 10 /- Diplomat S...cience has selected Diplomat,Specialty Pharmacy to...rge,scale, national Therapy Optimization Study for...wo year TOP MS study, is to examine the benefits o...on compliance, adherence and,patient outcomes. Tar...
(Date:10/9/2008)... American Campaign to Spread Awareness and Bring H...Oct. 9 /PRNewswire-USNewswire/ -- 133 million chil...e to causes such as natural,disaster, civil war, a...is,observing World Orphan Week by calling attentio... Multimedia News Release, go to:, http://www.prn...
Breaking Medicine Technology:Neuronascent, Inc. Receives Multiple Fundings for Its Neurogenesis Therapeutic Programs 2Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2U S Meat Industry Will Respond to World Cancer Research Fund Report 707 1HU scientist finds way to catch terrorists red handed 1047 1HU scientist finds way to catch terrorists red handed 1047 2Medivation Announces Participation in Acumen BioFin Rodman 26 Renshaw 9th Annual Healthcare Conference 1605 1Medivation Announces Participation in Acumen BioFin Rodman 26 Renshaw 9th Annual Healthcare Conference 1605 2Stem Cells Restore Memory in Mice 5082 1Stem Cells Restore Memory in Mice 5082 2Stem Cells Restore Memory in Mice 5082 3
... Potent Synergy, Activity and Patient Tolerance Su...ry Therapy, BARCELONA, Spain, April 12, 2007 /PRNe...y held biopharmaceutical company,today announced ...eron with or without ribavirin in treatment-naive ...results demonstrate that,omega interferon in combi...
... SOUTH SAN FRANCISCO, Calif., April 11, 2007 (PRI...biopharmaceutical company focused,on advancing can...ta(tm) (talotrexin) for Injection at the American ...ng April 14-18, 2007 in Los,Angeles, California. ,... with,paclitaxel in A549 non-small cell lung cance...
Other Medicine Technology:Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 2Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 3Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 4Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 2Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 3
This unique blanket is designed to be used for many surgical procedures, including but not limited to: laminectomies, spinal procedures, abdominal procedures, and transplants.
The chest access blanket is designed specifically for the thoracic surgery patient.
The cardiac access blanket helps maintain normothermia and allows unrestricted access to the patient.
The adult blanket provides full coverage for patients of all sizes. The generous size and versatility of these blankets include extra material for the shoulders and feet. The foot drape also reduces
Medicine Products: